US 7,744,873 B2Granted

Method for treating glaucoma comprising administering to a patient in need thereof a composition comprising an antibody against gremlin

AssigneesAlcon Inc., University of North Texas Health Science Center

InventorsAbbot F. Clark, Robert J. Wordinger

Life of this patent

Estimating the term…

Abstract

The present invention provides methods and kits for diagnosing and treating glaucoma.

Claims1

Dependent claims

A method for treating glaucoma comprising administering to a patient in need thereof a composition comprising a gremlin antagonist, wherein the gremlin antagonist is an antibody that binds to gremlin.

Dependencies are inferred from the claim text.

Facts

Application: 12/106,653Filed 21 Apr 2008 · continuation
Priority: 31 Oct 2001
Published: US 2008/0194515 A114 Aug 2008
Granted: 29 Jun 2010
Term ends: Not estimatedThe source records don’t support an estimate.

Classification13 codes

G01N 33/5023
For testing non-proliferative effects: on expression patterns
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 27/00
Drugs for disorders of the senses
A61P 27/06
Ophthalmic agents: antiglaucoma agents or miotics

Family

Application60/334,852Us provisional application · filed 31 Oct 2001
Application10/286,152Parent of this continuation · filed 31 Oct 2002
US 2008/0194515 A1Pre-grant publication · published 14 Aug 2008
US 7,405,192 B2Parent of this continuation
US 2003/0134308 A1Published application
US 7,744,873 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results